The problem of contraception legal guardianship: no coercive depot injection
Weber, M.
Pflege Zeitschrift 62(5): 293-295
2009
ISSN/ISBN: 0945-1129 PMID: 19492618 Document Number: 629163
Document emailed within 1 workday
Related Documents
Zhu, M.; Lei, Z.; Yang, D. 1999: Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception Zhonghua Fu Chan Ke Za Zhi 34(10): 621-623Dodegge, G. 2008: Practical problems in guardianship procedures from the perspective of a judge at a guardianship court Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 102(3): 156-161
Crossman, K.A.; Hardesty, J.L. 2018: Placing coercive control at the center: what are the processes of coercive control and what makes control coercive? Psychology of Violence 8(2): 196-206
Krashin, J.W.; Stuart, G.S.; Garrett, J.; Spector, H.; Bryant, A.G.; Charm, S.; Morse, J.E. 2017: Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion Obstetrics and gynecology 130(1): 109-117
Irwin, C.E.; Rickert, V.I. 2005: Coercive sexual experiences during adolescence and young adulthood: a public health problem Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 36(5): 359-361
Nissen, G.; Andersen, J.; Lauritsen, B.J. 1986: Registration of coercive measures. A prospective study of the use of coercive measures in a district emergency psychiatry department Ugeskrift for Laeger 148(13): 789-792
Nissen, G.; Andersen, J.; Lauritsen, B.J. 1986: Registration of coercive measures. A prospective study of the use of coercive measures in a district emergency psychiatry department Ugeskrift for Laeger 148(13): 789-792
Caroli, F. 1994: Placement requested by a 3rd party and mandatory placement. Guardianship, trusteeship, legal protection. Principles of application and principles of use La Revue du Praticien 44(20): 2763-2766
Patterson, C. 1998: Injection technique. Depot drugs Nursing Times 94(47): Suppl: 1-2
Bak, K.; Haugegaard, M.; Heltberg, O. 1993: Purulent arthritis and bursitis after local injection of depot steroids Ugeskrift for Laeger 155(14): 1047-1049
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Chaudhri, R.; Rizvi, F.; Afzal, M. 2010: Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as contraceptive Jpma. Journal of the Pakistan Medical Association 60(7): 536-540
Vasilev, D. 1978: Hormonal contraception using the oral depot preparation, Deposiston Akusherstvo i Ginekologiia 17(2): 147-151
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Guirguis-Blake, J. 2011: Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception American Family Physician 83(1): 35-36
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Kaunitz, A.M. 1996: Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer Journal of Reproductive Medicine 41(5 Suppl): 419-427
Hofmeyr, G.J.; Singata, M.; Lawrie, T.A. 2010: Copper containing intra-uterine devices versus depot progestogens for contraception Cochrane Database of Systematic Reviews 6: Cd007043
Prabhakaran, S.; Sweet, A. 2012: Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability Contraception 85(5): 453-457
Wanyonyi, S.Z.; Stones, W.R.; Sequeira, E. 2011: Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception Contraception 84(5): E17-E22